Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  1997-01-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.1997.03540280039031PMID 9002492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicting In‐Hospital Mortality The Importance of Functional Status Information

  1995cited by this paper
• A decision support tool for antibiotic therapy.

  1995cited by this paper
• The clinical-economic trial: promise, problems, and challenges.

  1995cited by this paper
• Cost of medication-related problems at a university hospital.

  1995cited by this paper
• Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention

  1995cited by this paper
• Drug-Related Morbidity and Mortality: A Cost-of-Illness Model

  1995cited by this paper
• Drug-related morbidity and mortality. A cost-of-illness model.

  1995cited by this paper
• Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

  1995cited by this paper
• Preventing Adverse Drug Events in Hospitalized Patients

  1994cited by this paper
• Eleven worthy aims for clinical leadership of health system reform.

  1994cited by this paper
• Prospective Surveillance of Imipenem/Cilastatin Use and Associated Seizures Using a Hospital Information System

  1993cited by this paper
• Polypharmacy

  1993cited by this paper
• Hospital Drug Formularies and Use of Hospital Services

  1993cited by this paper
• Using a hospital information system to assess the effects of adverse drug events.

  1993cited by this paper
• Drug-related emergency department visits and hospital admissions.

  1992cited by this paper
• Nursing assessments: patient severity of illness.

  1992cited by this paper
• Description of a computerized adverse drug event monitor using a hospital information system.

  1992cited by this paper
• Prevention of adverse drug events through computerized surveillance.

  1992cited by this paper
• Self-Reported Adverse Drug Reactions and Related Resource Use

  1992cited by this paper
• Computerized surveillance of adverse drug events in hospital patients*

  1991cited by this paper
• Validity and Reliability of a Pediatric Hematology Oncology Patient Acuity Tool

  1991cited by this paper
• The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.

  1991cited by this paper
• Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital.

  1991cited by this paper
• Level of nursing care required by the unstable angina patient.

  1990cited by this paper
• Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis.

  1988cited by this paper
• Computer surveillance of hospital-acquired infections and antibiotic use.

  1986cited by this paper
• Regression Analysis in Health Services Research: The Use of Dummy Variables

  1982cited by this paper
• Drug-related deaths among medical inpatients.

  1977cited by this paper
• Adverse drug reactions. A critical review.

  1975cited by this paper
• Adverse drug reactions. A critical review.

  1975cited by this paper
• Clinical problems with drugs.

  1975cited by this paper
• Drug-Induced Illness

  1974cited by this paper
• Hospital admissions due to adverse drug reactions. A report from the Boston Collaborative Drug Surveillance Program.

  1974cited by this paper
• Drug-induced illness leading to hospitalization.

  1974cited by this paper
• Drugs--remarkably nontoxic.

  1974cited by this paper
• Preventable drug reactions--causes and cures.

  1971cited by this paper

• Beyond black boxes: using explainable causal artificial intelligence to separate signal from noise in pharmacovigilance.

  2025cites this paper
• Effects of children’s criteria for identifying potentially inappropriate prescribing on prescription review by pharmacists: a before-after study

  2025cites this paper
• Drug-related emergency department visits in Qatar: a prospective cohort study

  2025cites this paper
• Understanding community pharmacists’ intentions to report adverse drug reactions in Saudi Arabia: a theory of planned behavior analysis

  2025cites this paper
• Clinical pharmacist-led medication review in patients with sepsis and septic shock in the intensive care unit: a non-randomized controlled study

  2025cites this paper
• Economic Burden of Medication Prescribing Faults in Hospitalized Patients: a Case Series and Microcosting Study from Serbia

  2025cites this paper
• SIDEKICK: A Semantically Integrated Resource for Drug Effects, Indications, and Contraindications

  2025cites this paper
• Wild medicine - exploring medication management challenges in transition and interaction across actors and health sectors related to older adults receiving polypharmacy: a qualitative study

  2025cites this paper
• Creation of a gold standard Dutch corpus of clinical notes for adverse drug event detection: the Dutch ADE corpus

  2025cites this paper
• Adverse Drug Reactions in an Intensive Care Unit of a Secondary Care Lithuanian Hospital: A Prospective Observational Study

  2025cites this paper
• Application of global trigger tool to determine the prevalence of adverse drug reactions in adult patients admitted to general and COVID-19 intensive care units

  2025cites this paper
• Methods used to identify and classify medication-related admissions and readmissions to hospitals: A systematic review.

  2025cites this paper
• A refined set of RxNorm drug names for enhancing unstructured data analysis in drug safety surveillance

  2025cites this paper
• Evaluation of Medication Errors among Inpatients in a Tertiary Government Hospital’s Pulmonary Medicine Service: A Cross-sectional Retrospective Study

  2025influential citation
• Errors and omissions: Incomplete or incorrect documentation on admission to inpatient rehabilitation

  2025cites this paper
• Economic impact and clinical benefits of clinical pharmacy interventions: A six-year multi-center study using an innovative medication management tool

  2025cites this paper
• Optimizing Drug Therapy Safety of Geriatric Orthopedic Patients by Providing Integrated Geriatric Care

  2025influential citation
• A deep learning-based method for predicting the frequency classes of drug side effects based on multi-source similarity fusion

  2025cites this paper
• Medication Safety in Acute Care Settings.

  2025cites this paper
• Using shared clinical decision support to reduce adverse drug events and improve patient safety

  2025cites this paper
• Renal adverse events associated with cyclin-dependent kinase 4/6 inhibitors.

  2025cites this paper
• Reassessing the impact of health IT: Hidden costs and consequences of vendor heterogeneity

  2024cites this paper
• FlexMol: A Flexible Toolkit for Benchmarking Molecular Relational Learning

  2024cites this paper
• Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors

  2024cites this paper
• Partnered pharmacist medication charting and prescribing in Australian hospitals

  2024cites this paper
• Comorbidities, drug-resistance and length of hospital stay among tuberculosis inpatients in Northeastern China: a retrospective observational study from 2013 to 2021

  2024cites this paper
• Analisi dei fattori determinanti l'adozione dell'Intelligenza Artificiale in sanità

  2024cites this paper
• Twenty-Five Years of Evolution and Hurdles in Electronic Health Records and Interoperability in Medical Research: Comprehensive Review

  2024cites this paper
• Improvement in Adverse Drug Reaction (ADR) Knowledge: A Pre- and Post-video Intervention Study Among Doctors

  2024cites this paper
• The Effect of Virtual Reality on Perioperative Pain management in patients undergoing Gastrointestinal Procedures and Surgeries: A Systematic Review of Clinical Trials.

  2024cites this paper
• Applying the Andersen behavioral model to the medication therapy management program: an approach for improving medication safety in older adults

  2024cites this paper
• Preoperative survey to evaluate the patients' allergy list and its relevance to perioperative care

  2024cites this paper
• The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar

  2024cites this paper
• A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care

  2024cites this paper
• Quality indicators for appropriate in‐hospital pharmacotherapeutic stewardship: An international modified Delphi study

  2024cites this paper
• Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review

  2024cites this paper
• Supramolecular interaction in the action of drug delivery systems

  2024cites this paper
• A Mathematical Model Based on Stratifying the Severity of Medical Errors for Building Scenarios for Clinical Cases With Branching

  2024cites this paper
• Il clinical risk management nell'esperienza dell'AOU Università degli Studi della Campania Luigi Vanvitelli

  2024cites this paper
• Why Don’t We Adequately Identify and Manage Adverse Drug Reactions despite Having the Needed Information?

  2024cites this paper
• Digital patient twins for personalized therapeutics and pharmaceutical manufacturing

  2024cites this paper
• Improving adverse drug event reporting by healthcare professionals

  2024cites this paper
• Njohuritë e farmacistëve të rrjetit të hapur mbi praktikat dhe sjelljet në lidhje me farmakovigjilencën

  2024cites this paper
• Factors Associated with the Public’s Intention to Report Adverse Drug Reactions to Community Pharmacists in the Makkah Region of Saudi Arabia: An Application of the Theory of Planned Behavior

  2024cites this paper
• Acute COPD exacerbations and in-hospital treatment-related problems: An observational study

  2024cites this paper
• Artificial intelligence-powered pharmacovigilance: A review of machine and deep learning in clinical text-based adverse drug event detection for benchmark datasets

  2024cites this paper
• Machine learning as a tool to identify inpatients who are not at risk of adverse drug events in a large dataset of a tertiary care hospital in the USA

  2023cites this paper
• Medication error during nonoperating room anesthesia—a case report

  2023cites this paper
• Chloroquine-induced Photosensitive Dermatoses: A Case Report

  2023cites this paper
• Clinical and economic impact of adverse drug reactions in hospitalised patients: prospective matched nested case–control study in Ethiopia

  2023cites this paper
• Treatment-related problems and their cost among patients hospitalised with asthma exacerbation

  2023cites this paper
• DKADE: a novel framework based on deep learning and knowledge graph for identifying adverse drug events and related medications

  2023cites this paper
• Distilling Large Language Models for Biomedical Knowledge Extraction: A Case Study on Adverse Drug Events

  2023cites this paper
• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses

  2023cites this paper
• Medication review in hospitalised patients to reduce morbidity and mortality.

  2023cites this paper
• Evaluation of Suspected Adverse Drug Reaction and Prescribing Patterns of Perioperative Antimicrobials in Major Surgical Patients of Tertiary Care Hospital of Bihar

  2023cites this paper
• Implementation of barcode medication administration (BMCA) technology on infusion pumps in the operating rooms

  2023cites this paper
• Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine

  2023cites this paper
• Incidence and Economic Burden of Adverse Drug Reactions in Hospitalization: A Prospective Study in Korea

  2023cites this paper
• A systematic review on pharmacist-led pharmaceutical care optimization through virtual platforms

  2023cites this paper
• Electronic health record-based prediction models for in-hospital adverse drug event diagnosis or prognosis: a systematic review

  2023cites this paper
• Evaluating the Economic Impact of the PedAMINES App in Reducing Medication Errors in Pediatric Emergency Care: Cost-Effectiveness Analysis

  2023cites this paper
• Generalizability of machine learning methods in detecting adverse drug events from clinical narratives in electronic medical records

  2023cites this paper
• Clinical profile of adverse drug reactions in patients admitted to internal medicine wards of a tertiary care hospital

  2023cites this paper
• Appraising the Role of Pharmacists in Medication Reconciliation at Hospital Discharge: A Field-Based Study

  2023cites this paper
• Atualização dos rastreadores para detecção de eventos adversos a medicamentos em pacientes hematológicos

  2023cites this paper
• Adverse drug events in Chinese elder inpatients: a retrospective review for evaluating the efficiency of the Global Trigger Tool

  2023cites this paper
• Applied Clinical Informatics Medication Reconciliation During Transitions of Care Across Institutions: A quantitative analysis of challenges and opportunities.

  2023cites this paper
• The evaluation of antimicrobial stewardship for bacterial meningitis in neonates

  2023cites this paper
• Drug-Related Problems in Elderly Patients Attended to by Emergency Services

  2023cites this paper
• Comprehensive Review of Drug-Drug Interaction Prediction Based on Machine Learning: Current Status, Challenges, and Opportunities

  2023cites this paper
• Identification of Medication Prescription Errors and Factors of Clinical Relevance in 314 Hospitalized Patients for Improved Multidimensional Clinical Decision Support Algorithms

  2023cites this paper
• Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow

  2023cites this paper
• Medication Reconciliation during Transitions of Care Across Institutions: A Quantitative Analysis of Challenges and Opportunities

  2023cites this paper
• Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study

  2022cites this paper
• EXPLORATORY STUDY ABOUT KNOWLEDGE, ATTITUDE AND PRACTICE ABOUT PHARMACOVIGILANCE AND ADR REPORTING AMONG RESIDENTS OF A TERTIARY CARE TEACHING HOSPITAL

  2022cites this paper
• A Data-Driven Medical Decision Framework for Associating Adverse Drug Events with Drug-Drug Interaction Mechanisms

  2022cites this paper
• Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data.

  2022cites this paper
• Health Systems and Their Impact on Improving Health Services: A Simple Review

  2022cites this paper
• Exploring the prevalence and characteristics of adverse drug events among older adults in South Korea using a national health insurance database

  2022cites this paper
• Evaluating reduction in medical costs associated with pharmacists' presence in the emergency department using a novel cost avoidance framework.

  2022cites this paper
• Identification of polypharmacy patterns in new‐users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining

  2022cites this paper
• Impact of suspected adverse drug reactions on mortality and length of hospital stay in the hospitalised patients: a meta-analysis

  2022cites this paper
• Pharmacist's Knowledge and Behaviors Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process in Türkiye.

  2022cites this paper
• The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events

  2022cites this paper
• Analysis of potential drug interactions in medical clinic sector in a Hospital of João Pessoa - PB

  2022cites this paper
• Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

  2022cites this paper
• A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting

  2022cites this paper
• Systematic Review of Risk Factors Assessed in Predictive Scoring Tools for Drug-Related Problems in Inpatients

  2022cites this paper
• Developing an Ontology for Documenting Adverse Events While Avoiding Pitfalls

  2022cites this paper
• Artificial Intelligent Context-Aware Machine-Learning Tool to Detect Adverse Drug Events from Social Media Platforms

  2022cites this paper
• The value of incorporating patient-consulted medication reconciliation in influencing drug-related actions in the outpatient rheumatology setting

  2022cites this paper
• Automatic Detection of Adverse Drug Events in Geriatric Care: Study Proposal

  2022cites this paper
• HLA pharmacogenetic markers of drug hypersensitivity from the perspective of the populations of the Greater Middle East.

  2022cites this paper
• Development of the Leapfrog Group's Bar Code Medication Administration Standard to Address Hospital Inpatient Medication Safety.

  2022cites this paper
• Lessons Learned When Discharging Older Adults to Skilled Nursing Facilities

  2022cites this paper
• Evaluation of Factors Associated with Adverse Drug Events in South Korea Using a Population-Based Database

  2022cites this paper
• Factors affecting patient safety culture in a university hospital under the universal health insurance system: A cross-sectional study from Japan

  2022cites this paper
• Improving the specificity of drug-drug interaction alerts: Can it be done?

  2022cites this paper
• Frequency, Characteristics, and Predictive Factors of Adverse Drug Events in an Adult Emergency Department according to Age: A Cross-Sectional Study

  2022cites this paper